A randomized, double-blind, placebo-controlled, parallel-group, Proof-of-Concept (PoC) study to assess the efficacy, safety and tolerability of SAR440340, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Administered By

Awarded By

Contributors

Start/End

  • January 16, 2019 - May 27, 2020